{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:48:55Z","timestamp":1790740135674,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"E-Da Hospital of the Republic of China","award":["EDAHP106018"],"award-info":[{"award-number":["EDAHP106018"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cca.2018.05.022","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T11:54:45Z","timestamp":1527594885000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients"],"prefix":"10.1016","volume":"484","author":[{"given":"Teng-Hung","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Mei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Yiing","family":"Houng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-5023","authenticated-orcid":false,"given":"Yau-Jiunn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.05.022_bb0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009833","article-title":"Impact of dialysis dependence on prognosis in patients with myocardial infarction: an 11-year population-based study","volume":"97","author":"Fu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2018.05.022_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/snep.2002.35973","article-title":"New clinical practice guidelines for chronic kidney disease: a framework for K\/DOQI","volume":"22","author":"Patel","year":"2002","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2018.05.022_bb0015","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1681\/ASN.2007020220","article-title":"End-stage renal disease in the United States: an update from the United States renal data system","volume":"18","author":"Foley","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.022_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1525-139X.2003.16023.x","article-title":"Cardiovascular disease in chronic renal failure: pathophysiologic aspects","volume":"16","author":"London","year":"2003","journal-title":"Semin. Dial."},{"key":"10.1016\/j.cca.2018.05.022_bb0025","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.022_bb0030","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1248\/bpb.18.1755","article-title":"Characterization of binding site of uremic toxins on human serum albumin","volume":"18","author":"Sakai","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cca.2018.05.022_bb0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI108031","article-title":"Uricosuric agents in uremic sera. Identification of indoxyl sulfate and hippuric acid","volume":"55","author":"Boumendil-Podevin","year":"1975","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cca.2018.05.022_bb0040","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1046\/j.1523-1755.2001.59780278.x","article-title":"Hippurate participates in the correction of metabolic acidosis","volume":"78","author":"Dzurik","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cca.2018.05.022_bb0045","first-page":"79","article-title":"Hippurate participation in the inhibition of glucose utilization in renal failure","volume":"10","author":"Spustova","year":"1987","journal-title":"Czech Med."},{"key":"10.1016\/j.cca.2018.05.022_bb0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0378-4347(00)82773-5","article-title":"Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification","volume":"490","author":"Spustova","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2018.05.022_bb0055","first-page":"723","article-title":"Secretory activity and aryl acid content of serum, urine and cerebrospinal fluid in normal and uremic man","volume":"85","author":"Porter","year":"1975","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cca.2018.05.022_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1471-4159.2002.01108.x","article-title":"Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain","volume":"83","author":"Ohtsuki","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2018.05.022_bb0065","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1046\/j.1523-1755.2001.59780278.x","article-title":"Hippu-rate participates in the correction of metabolic acidosis","volume":"78","author":"Dz\u00farik","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cca.2018.05.022_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4070\/kcj.2016.46.2.117","article-title":"Heart disease in disorders of muscle, neuromuscular transmission, and the nerves","volume":"46","author":"Finsterer","year":"2016","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.cca.2018.05.022_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/7b2c04df-8592-4fb7-8608-3039db28b504","article-title":"Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease","volume":"7","author":"Namdar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2018.05.022_bb0080","doi-asserted-by":"crossref","first-page":"F431","DOI":"10.1152\/ajprenal.00199.2012","article-title":"Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone","volume":"303","author":"Krieger","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cca.2018.05.022_bb0085","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1253\/circj.CJ-10-0355","article-title":"Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T","volume":"74","author":"Negishi","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.cca.2018.05.022_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pcad.2009.05.002","article-title":"Clinical impact of left ventricular hypertrophy and implications for regression","volume":"52","author":"Artham","year":"2009","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2018.05.022_bb0095","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1681\/ASN.V471486","article-title":"Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients","volume":"4","author":"Harnett","year":"1994","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.022_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.echo.2005.10.006","article-title":"Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease","volume":"19","author":"Sharma","year":"2006","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.cca.2018.05.022_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/mje.2002.121536","volume":"15","author":"Gardin","year":"2002","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.cca.2018.05.022_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCULATIONAHA.106.661983","article-title":"Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study","volume":"116","author":"Kasner","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2018.05.022_bb0115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9149(87)91133-7","article-title":"Echocardiographic criteria for left ventricular hypertrophy: the Framingham heart study","volume":"59","author":"Levy","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2018.05.022_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.022_bb0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0021-9673(00)96096-5","article-title":"Hippuric acid and 3-carboxy- 4-methyl-5-propyl-2-furanpropionic acid in serum and urine. Analytical approaches and clinical relevance in kidney diseases","volume":"500","author":"Liebich","year":"1990","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2018.05.022_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-4347(00)82612-2","article-title":"Determination of hippuric acid and furanic acid in serum of dialysis patients and control persons by high-performance liquid chromatography","volume":"495","author":"Pickert","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2018.05.022_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000185973","article-title":"Phenylacetylglutamine and hippuric acid in uremic and healthy subjects","volume":"55","author":"Zimmerman","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.cca.2018.05.022_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4684-5445-1_14","article-title":"Pathogenesis and consequences of the alteration of glucose metabolism in renal insufficiency","volume":"223","author":"Dzurik","year":"1987","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cca.2018.05.022_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(89)90134-4","article-title":"Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failure","volume":"185","author":"Schoots","year":"1989","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2018.05.022_bb0150","first-page":"191","article-title":"Secondary cardiomyopathy accompanied by neuromuscular disorders","volume":"58","author":"Hayashi","year":"2000","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.cca.2018.05.022_bb0155","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/0006-2952(87)90661-7","article-title":"Contributions of hippurate, indoxyl sulfate, and o-hydroxyhippurate to impaired ligand binding by plasma in azotemic humans","volume":"36","author":"Gulyassy","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cca.2018.05.022_bb0160","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/clinchem\/34.6.1022","article-title":"Are the classical markers sufficient to describe uremic solute accumulation in dialyzed patients? Hippurates reconsidered","volume":"34","author":"Schoots","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.05.022_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0024-3205(81)90241-1","article-title":"Role of hippurate in acidosis induced adaptation in renal gamma-glutamyltransferase","volume":"29","author":"Welbourne","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2018.05.022_bb0170","first-page":"308","article-title":"Renal ammonia and bicarbonate production in chronic renal failure","volume":"16","author":"Dass","year":"1990","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.cca.2018.05.022_bb0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.arrt.2003.08.002","article-title":"Protein-bound uremic retention solutes","volume":"10","author":"Brunet","year":"2003","journal-title":"Adv. Ren. Replace. Ther."},{"key":"10.1016\/j.cca.2018.05.022_bb0180","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000435838","article-title":"Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment","volume":"5","author":"Di Lullo","year":"2015","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.cca.2018.05.022_bb0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000479253","article-title":"Uremia retention molecules and clinical outcomes","volume":"191","author":"Barreto","year":"2017","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.cca.2018.05.022_bb0190","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2215\/CJN.04571007","article-title":"The challenge of sudden death in dialysis patients","volume":"3","author":"Ritz","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2018.05.022_bb0195","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1525-139X.2008.00454.x","article-title":"Hypertrophy and fibrosis in the cardiomyopathy of uremia\u2013beyond coronary heart disease","volume":"21","author":"Gross","year":"2008","journal-title":"Semin. Dial."},{"key":"10.1016\/j.cca.2018.05.022_bb0200","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ki.2009.35","article-title":"Left ventricular hypertrophy in renal disease: beyond preload and afterload","volume":"75","author":"Ritz","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2018.05.022_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1542-4758.2008.00275.x","article-title":"Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients","volume":"12","author":"Mominadam","year":"2008","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.cca.2018.05.022_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000100106","article-title":"Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis","volume":"27","author":"Steigerwalt","year":"2007","journal-title":"Am. J. Nephrol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118302316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118302316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T14:30:26Z","timestamp":1661351426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118302316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"alternative-id":["S0009898118302316"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.05.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}